Pharmacologic Agents for Pediatric Neuroimmune Disorders
- 31 December 2010
- journal article
- review article
- Published by Elsevier BV in Seminars in Pediatric Neurology
- Vol. 17 (4), 245-253
- https://doi.org/10.1016/j.spen.2010.10.007
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Mycophenolate mofetil: A possible therapeutic agent for children with juvenile dermatomyositisArthritis Care & Research, 2010
- RESPONSE TO IMMUNOTHERAPY IN A 20-MONTH-OLD BOY WITH ANTI-NMDA RECEPTOR ENCEPHALITISNeurology, 2010
- NMDA RECEPTOR ENCEPHALITIS MIMICKING SERONEGATIVE NEUROMYELITIS OPTICANeurology, 2010
- Patient with neuromyelitis optica and inflammatory demyelinating lesions comprising whole spinal cord from C2 level till conus: case reportBMC Neurology, 2009
- Cyclophosphamide therapy in pediatric multiple sclerosisNeurology, 2009
- Anti–N‐methyl‐D‐aspartate receptor (NMDAR) encephalitis in children and adolescentsAnnals of Neurology, 2009
- Antibody to aquaporin-4 in the long-term course of neuromyelitis opticaBrain, 2008
- Pharmacokinetic study of oral prednisolone compared with intravenous methylprednisolone in patients with juvenile dermatomyositisArthritis Care & Research, 2008
- A patient with encephalitis associated with NMDA receptor antibodiesNature Clinical Practice Neurology, 2007
- Prospective study on anti-ganglioside antibodies in childhood Guillain-Barre syndromeArchives of Disease in Childhood, 2007